Profile
Stephen Bloor is the founder and the Chief Executive Officer of Videregen Ltd., a company founded in 2011.
He also served as the Technical Director of Tissue Science Laboratories Ltd.
from 2000 to 2015.
Stephen Bloor active positions
| Companies | Position | Start |
|---|---|---|
Videregen Ltd.
 Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | Chief Executive Officer | 31/12/2010 |
Former positions of Stephen Bloor
| Companies | Position | End |
|---|---|---|
Tissue Science Laboratories Ltd.
 Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Tissue Science Laboratories Ltd. develops and markets tissue implant products. The company was founded on January 7, 1999 and is headquartered in Watford, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Tissue Science Laboratories Ltd.
Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Tissue Science Laboratories Ltd. develops and markets tissue implant products. The company was founded on January 7, 1999 and is headquartered in Watford, the United Kingdom. | Health Technology |
Videregen Ltd.
Videregen Ltd. BiotechnologyHealth Technology Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Stephen Bloor